Robert Simmons
Stock Analyst at Rosenblatt
(1.89)
# 3,148
Out of 5,172 analysts
42
Total ratings
48%
Success rate
0.42%
Average return
Main Sectors:
Stocks Rated by Robert Simmons
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WDAY Workday | Maintains: Buy | $180 → $150 | $135.96 | +10.33% | 10 | Feb 25, 2026 | |
| BL BlackLine | Maintains: Buy | $62 | $39.11 | +58.53% | 3 | Feb 11, 2026 | |
| OS OneStream | Downgrades: Neutral | $26 → $24 | $23.77 | +0.97% | 2 | Jan 7, 2026 | |
| PHR Phreesia | Maintains: Buy | $36 → $34 | $11.86 | +186.68% | 6 | Apr 14, 2025 | |
| ASAN Asana | Maintains: Neutral | $20 | $6.65 | +200.75% | 6 | Mar 12, 2024 | |
| MNDY monday.com | Upgrades: Buy | $170 | $73.85 | +130.20% | 6 | Nov 7, 2023 | |
| GDRX GoodRx Holdings | Upgrades: Buy | $9.5 | $2.03 | +367.98% | 2 | Aug 10, 2023 | |
| PCTY Paylocity Holding | Upgrades: Buy | $245 | $112.52 | +117.74% | 2 | Mar 30, 2023 | |
| PAYC Paycom Software | Upgrades: Buy | $350 | $124.82 | +180.40% | 3 | Mar 30, 2023 | |
| TDOC Teladoc Health | Maintains: Buy | $45 → $40 | $5.35 | +647.66% | 2 | Oct 25, 2022 |
Workday
Feb 25, 2026
Maintains: Buy
Price Target: $180 → $150
Current: $135.96
Upside: +10.33%
BlackLine
Feb 11, 2026
Maintains: Buy
Price Target: $62
Current: $39.11
Upside: +58.53%
OneStream
Jan 7, 2026
Downgrades: Neutral
Price Target: $26 → $24
Current: $23.77
Upside: +0.97%
Phreesia
Apr 14, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $11.86
Upside: +186.68%
Asana
Mar 12, 2024
Maintains: Neutral
Price Target: $20
Current: $6.65
Upside: +200.75%
monday.com
Nov 7, 2023
Upgrades: Buy
Price Target: $170
Current: $73.85
Upside: +130.20%
GoodRx Holdings
Aug 10, 2023
Upgrades: Buy
Price Target: $9.5
Current: $2.03
Upside: +367.98%
Paylocity Holding
Mar 30, 2023
Upgrades: Buy
Price Target: $245
Current: $112.52
Upside: +117.74%
Paycom Software
Mar 30, 2023
Upgrades: Buy
Price Target: $350
Current: $124.82
Upside: +180.40%
Teladoc Health
Oct 25, 2022
Maintains: Buy
Price Target: $45 → $40
Current: $5.35
Upside: +647.66%